Professor David Becker obtained his BSc in Biology in 1985 and his PhD in 1988 at University College London. In 1994, he was awarded a Royal Society Research Fellowship and, in 2008, was made full Professor at UCL. In 2013, he moved to Singapore to join the newly formed Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. He has published >150 research articles and book chapters, with >6,200 citations and a publication H-Index of 48 and acts as a reviewer for many international journals and international grant funding agencies. For his translational research, he has 33 worldwide patents pending and granted. In 2006, he was a founding scientist of CoDaTherapeutics Inc, (now Ocunexus) to develop Nexagon, a drug, which promotes wound healing in skin and cornea. Recently, he developed a perturbed wound healing model, which recapitulates many of the features of human chronic wounds, which is not seen in any other animal wound models.